The ultrasensitive, high-performance SMCxPRO® immunoassay platform enables the measurement of previously undetectable proteins, such as biomarkers of neurodegenerative disease. The study detailed in this poster reviewed the measurement of both well-established and novel biomarkers associated with Alzheimer's disease in samples of human cerebrospinal fluid (CSF) and plasma utilizing SMC® immunoassay kits. These fit-for-purpose immunoassays offer researchers unparalleled flexibility, empowering them to explore a wide array of proteins linked to Alzheimer's disease and other neurological disorders. Download this poster to learn more.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.